408 evidence-linked molecules — 5 currently mapped to an Abiozen canonical molecule, 403 not yet mapped. Ordering is alphabetical and neutral; this is an evidence view, not a ranking.
Prioritize — inhibition potency (IC50) →| Molecule | Representative activity | Evidence | Abiozen identity | Commercial |
|---|---|---|---|---|
|
CHEMBL93208
CHEMBL93208
|
Ki 0.41 nM | 1 | Not yet mapped | — |
|
CHEMBL93354
CHEMBL93354
|
IC50 36 nM | 1 | Not yet mapped | — |
|
CHEMBL93505
CHEMBL93505
|
IC50 1000000 nM | 1 | Not yet mapped | — |
|
CHEMBL93507
CHEMBL93507
|
IC50 67000 nM | 2 | Not yet mapped | — |
|
CHEMBL93526
CHEMBL93526
|
Ki 260 nM | 1 | Not yet mapped | — |
|
CHEMBL93558
CHEMBL93558
|
IC50 217000 nM | 1 | Not yet mapped | — |
|
CHEMBL93847
CHEMBL93847
|
IC50 338 nM | 1 | Not yet mapped | — |
|
CHEMBL93931
CHEMBL93931
|
IC50 21000 nM | 2 | Not yet mapped | — |
|
CHEMBL94046
CHEMBL94046
|
IC50 18700 nM | 1 | Not yet mapped | — |
|
CHEMBL9408
CHEMBL9408
|
IC50 16 nM | 1 | Not yet mapped | — |
|
CHEMBL94147
CHEMBL94147
|
IC50 291 nM | 1 | Not yet mapped | — |
|
CHEMBL94278
CHEMBL94278
|
Ki 1.1 nM | 1 | Not yet mapped | — |
|
CHEMBL94312
CHEMBL94312
|
IC50 80 nM | 1 | Not yet mapped | — |
|
CHEMBL9433
CHEMBL9433
|
IC50 400 nM | 1 | Not yet mapped | — |
|
CHEMBL94597
CHEMBL94597
|
IC50 298 nM | 1 | Not yet mapped | — |
|
CHEMBL94630
CHEMBL94630
|
IC50 123 nM | 1 | Not yet mapped | — |
|
CHEMBL94647
CHEMBL94647
|
IC50 466 nM | 1 | Not yet mapped | — |
|
CHEMBL94908
CHEMBL94908
|
IC50 105 nM | 1 | Not yet mapped | — |
|
CHEMBL94955
CHEMBL94955
|
IC50 134900 nM | 1 | Not yet mapped | — |
|
CHEMBL95088
CHEMBL95088
|
IC50 26 nM | 1 | Not yet mapped | — |
|
CHEMBL95089
CHEMBL95089
|
IC50 54 nM | 1 | Not yet mapped | — |
|
CHEMBL9512
CHEMBL9512
|
IC50 500 nM | 1 | Not yet mapped | — |
|
CHEMBL9527
CHEMBL9527
|
IC50 5000 nM | 1 | Not yet mapped | — |
|
CHEMBL9561
CHEMBL9561
|
IC50 22000 nM | 1 | Not yet mapped | — |
|
CHEMBL9565
CHEMBL9565
|
IC50 190000 nM | 1 | Not yet mapped | — |